IIROC Trading Halt - BETR

The following issues have been halted by IIROC:

Company: BetterLife Pharma Inc.

CSE Symbol: BETR

All Issues: Yes

Reason: At the request of the Company Pending News

Halt Time (ET): 8:10 AM

IIROC can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. IIROC is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada .

SOURCE Investment Industry Regulatory Organization of Canada (IIROC) - Halts/Resumptions

View original content: https://www.newswire.ca/en/releases/archive/December2021/22/c0660.html

News Provided by Canada Newswire via QuoteMedia

cse:betrpharmaceutical investing
BETR:CNX
The Conversation (0)
InMed Announces Results of 2025 Annual General and Special Meeting

InMed Announces Results of 2025 Annual General and Special Meeting

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today confirmed that, at its annual general and special meeting of shareholders... Keep Reading...
InMed Provides Update on BayMedica Commercial Business

InMed Provides Update on BayMedica Commercial Business

InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates for diseases with high unmet medical needs, today released the following statement.Recently, H.R. 5371, the "Continuing... Keep Reading...
Thian Chew, CEO of Invion

Invion Advances Global Strategy With New Licencing Agreement

Invion (ASX:IVX) has taken a major step forward with a new global licencing agreement that streamlines its rights across key cancer and infectious disease programs. The move gives the company a clearer path to advance its Photosoft technology, expand market opportunities and strengthen... Keep Reading...
Blank pill bottle spilling a variety of pharmaceutical pills and capsules.

5 Biggest Pharmaceutical ETFs in 2025

The global pharmaceutical market is set to surpass a total value of US$1.75 trillion by the end of the decade, according to Evaluate Pharma.Experienced and novice investors alike may want to consider pharmaceutical exchange-traded funds (ETFs) as a way to gain exposure to the top pharma... Keep Reading...
InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901

InMed Announces Successful Completion of Pharmacokinetic Studies in Large Animal Model for Its Alzheimer's Disease Candidate INM-901

Data demonstrate a favorable bioavailability profile of INM-901 oral formulationData will support design and planning of first in human clinical trialsPreparing for pre-IND meeting with the FDA InMed Pharmaceuticals Inc. (NASDAQ: INM) ("InMed" or the "Company"), a pharmaceutical company... Keep Reading...
InMed Pharmaceuticals (NASDAQ:INM)

InMed Pharmaceuticals

Keep Reading...

Latest News

Interactive Chart

Latest Press Releases

Brunswick Exploration Closes Upsized Non-Brokered Private Placement of $2.1 M

Nextech3D.ai Provides Shareholder Update on Krafty Labs Acquisition and Announces New CEO Investment

International Lithium Corp. Reports Results of 2025 Annual General Meeting

Kinetiko Commences Trading on North American OTC Market

Related News

Gold Investing

What Was the Highest Price for Gold?

Precious Metals Outlook

Precious Metals Outlook: Australia Edition

Precious Metals Outlook: World Edition

Battery Metals Investing

Brunswick Exploration Closes Upsized Non-Brokered Private Placement of $2.1 M

Base Metals Investing

International Lithium Corp. Reports Results of 2025 Annual General Meeting

Energy Investing

Kinetiko Commences Trading on North American OTC Market